tirzepatide surmount trials Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial | Diabetes Therapy In the SURMOUNT-5 phase 3b

Clinical trials consistently demonstrate that once-weekly TZP leads to substantial and sustained reductions in body weight often exceeding 15%20% and marked improvements in glycaemic control, with reductions in HbA1c surpassing many existing therapies

Even among family members, sometimes the genetics may vary slightly or at least the expression of a certain gene

Critics have questioned its accuracy and reproducibility, expressing concerns that excessive reliance on algorithms might lead to a narrow or oversimplified understanding of the complexity inherent in Chinese medicine [673, 674]

It helps regulate appetite centers in the brain, slows gastric emptying, and reduces post-meal glucagon release

NPR's Will Stone reports